Примери за използване на Community procedure на Английски и техните преводи на Български
{-}
-
Official
-
Colloquial
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
COUNCIL REGULATION(EC) No 520/94 of 7 March 1994 establishing a Community procedure for administering quantitative quotas.
Whereas a Community procedure must be laid down for assessing whether an active substance can be entered on the Community list;
(k) recording the status of marketing authorisations for medicinal products granted in accordance with Community procedures;
Laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.
Council Regulation(EC) No 520/94 of 7 March 1994(Quota Regulation) established a Community procedure for administering quantitative quotas.
Regulation… laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal originOJ 1997 L 67, p.
In order to monitor and reduce these effects, specific requirements for traceability and a Community procedure for notifying serious adverse reactions and events should be set out.
Regulation of 22 July 1993 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products OJ 1993 L 214, p.
Whereas in order to facilitate compliance with Treaty obligations andto ensure the mobility of cockpit personnel, a Community procedure should be introduced for the acceptance of licences and qualifications of such personnel;
Regulation(EC) No 726/2004, laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, as amended.
In order to protect human health, animal health and the environment,feed additives should undergo a safety assessment through a Community procedure before being placed on the market, used or processed within the Community. .
Whereas Articles 10 to 18 of Directive 90/220/EEC lay down a Community procedure enabling the competent authority of a Member State to give consent to the placing on the market of products containing, or consisting of, genetically modified organisms;
In addition to evaluation of applications for MRLs, the Agency will provide assistance to the Commission with the review of Regulation(EEC) No 2377/90 laying down a Community procedure for the establishment of MRLs for veterinary medicinal products in foodstuffs of animal origin.
(32) It is necessary to provide for the coordinated implementation of Community procedures for the authorisation of medicinal products, and of the national procedures of Member States which have already been harmonised to a considerable degree by Directives 2001/83/EC and 2001/82/EC.
It is appropriate to establish Community rules for those genera andspecies of fruit plant which are of major economic importance in the Community, with a Community procedure for adding further genera and species later to the list of genera and species to which this Directive applies.
COUNCIL REGULATION(EC) No 3286/94 of 22 December 1994 laying down Community procedures in the field of the common commercial policy in order to ensure the exercise of the Community's rights under international trade rules, in particular those established under the auspices of the World Trade Organization.
Consequently, it is necessary to establish that this Regulationis without prejudice to the competence conferred on the EMEA by Community legislation, including powers conferred by Council Regulation(EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(20).
Council Decision 1999/280 of 22 April 1999 regarding a Community procedure for information and consultation on crude oil supply costs and the consumer prices of petroleum products.
In writing.-(PT) I voted in favour of the report on the proposed regulation of the European Parliament and of the Council amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation(EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.
Directive 2008/92/EC of 22 October 2008 concerning a Community procedure to improve the transparency of gas and electricity prices charged to industrial end-users.
The report by Christofer Fjellner, on behalf of theCommittee on the Environment, Public Health and Food Safety, on the proposal for a regulation of the European Parliament and of the Council amending, as regards information to the general public on medicinal products for human use subject to medical prescription, Regulation(EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency- C6-0517/2008-.
Council Regulation(EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin.
(1) Commission Regulation(EC)No 1873/2003 of 24 October 2003 amending Annex II to Council Regulation(EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin is invalid in its entirety;
(1) Article 71 of Council Regulation(EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products(4) provides that, within six years of the entry into force of the Regulation, the Commission is to publish a general report on the experience acquired as a result of the operation of the procedures laid down in the Regulation.
Regulation(EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency(EMA) OJ 2004 L 136, p.
OPINION Proposal for a Regulation of the European Parliament and of the Council laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, and repealing Regulation(EEC) No 2377/90.
(2) Commission Regulation(EC) No 1148/2005 of 15 July 2005 amending AnnexI to Council Regulation(EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards penethamate[2] is to be incorporated into the Agreement.
(2) Commission Regulation(EC) No 1851/2004 of 25 October 2004 amending Annex I to Council Regulation(EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits for veterinary medicinal products in foodstuffs of animal origin[2] is to be incorporated into the Agreement.
Whereas Commission Regulation(EC)No 2010/96 of 21 october 1996 amending Annex II to Council Regulation(EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(2), is to be incorporated into the Agreement.
If an MRL has been established forthe substance object of the application by Council Regulation(EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(8), section 2.6.2 will not be subject to evaluation by the CRL.